Suchergebnisse - "LI CHUNLEI"

PubPharm (25)

1

A preparation method for mRNA-LNPs with improved properties

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2023

von Geng, C. | Zhou, K. | Yan, Y. | +11

2

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer : a randomized, open-label, active-controlled, single-center, phase II clinical trial

enthalten in: Investigational new drugs | 2022

von Wang, L. | Cao, J. | Li, C. | +11

3

Regulated bioanalysis of liposomal amphotericin B to support pharmacokinetic studies of liposomal drugs

enthalten in: Bioanalysis | 2022

von Zhang, X. | Ji, Y. | Liu, J. | +5

4

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial

enthalten in: Investigational new drugs | 2021

von Wang, L. | Cao, J. | Li, C. | +11

5

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial

enthalten in: Investigational new drugs | 2021

von Wang, L. | Cao, J. | Li, C. | +11

6

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial

enthalten in: Investigational new drugs | 2021

von Wang, L. | Cao, J. | Li, C. | +11

7

Direct quantitation of free, encapsulated, total doxorubicin and doxorubicinol in stabilized frozen human plasma to support a BE study of liposomal doxorubicin

enthalten in: Journal of pharmaceutical and biomedical analysis | 2020

von Ji, Y. | Zhang, X. | Liu, J. | +4

8

Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s : pharmacokinetics, toxicity and preliminary efficacy

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Yang, J. | Shi, Y. | Li, C. | +8

9

Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect

enthalten in: International journal of pharmaceutics | 2014

von Li, C. | Zhao, X. | Deng, C. | +3

10

Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan

enthalten in: International journal of pharmaceutics | 2013

von Li, C. | Zhao, X. | Wang, Y. | +6